header logo image


Page 103«..1020..102103104105..110120..»

UPDATE — Institutional Shareholder Services Inc. Recommends Sernova’s Shareholders Vote FOR all Management Nominees on Management’s White Proxy

April 15th, 2023 12:16 am

LONDON, Ontario, April 14, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Corporation”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, is pleased to announce that Institutional Shareholders Services Inc. (“ISS”) has recommended Sernova’s shareholders vote FOR all of Sernova’s management nominees using only management’s WHITE proxy.

The rest is here:
UPDATE -- Institutional Shareholder Services Inc. Recommends Sernova’s Shareholders Vote FOR all Management Nominees on Management’s White Proxy

Read More...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

April 15th, 2023 12:16 am

Regulated Information

Here is the original post:
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Read More...

PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

April 15th, 2023 12:16 am

PETACH TIKVA, Israel, April 14, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced it has received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(1) requires listed companies to maintain stockholders’ equity of at least $10,000,000, and the Company’s stockholders’ equity was $5,829,000 as of December 31, 2022. In accordance with Nasdaq rules, the Company has 45 calendar days, or until May 25, 2023, to submit a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance. The notification letter has no immediate effect on the Company’s listing on the Nasdaq Capital Market, and during the grace period, as may be extended, the Company’s ordinary shares will continue to trade on Nasdaq under the symbol “PYPD”.

See the original post:
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Read More...

Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

April 15th, 2023 12:16 am

BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held April 23 - 27 in New Orleans, Louisiana.

Read the original post:
Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Read More...

23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

April 15th, 2023 12:16 am

ORLANDO, Fla., April 14, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced results from the Phase 1 portion of its Phase 1/2a study evaluating 23ME-00610, an investigational antibody targeting CD200R1. 23ME-00610 demonstrated an acceptable safety and tolerability profile, with favorable pharmacokinetics (PK) and peripheral saturation of the CD200R1 target. Based on the Phase 1 data, a dose of 23ME-00610 given at 1400 mg intravenously every 3 weeks was selected for evaluation of anti-tumor activity in the ongoing Phase 2a portion of the Phase 1/2a (Phase 2a) 23ME-00610 study.

See the article here:
23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

Read More...

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

April 15th, 2023 12:16 am

CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on April 13, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended February 26, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission.

Original post:
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

Read More...

Predicine to Introduce PredicineALERT™ MRD Assay and Present Twelve Posters at AACR 2023 Conference

April 15th, 2023 12:16 am

New research demonstrates the value of genomic and epigenomic methylation sequencing capabilities of Predicine liquid biopsy platform for biomarker discovery, treatment selection, therapy monitoring and minimal residual disease monitoring New research demonstrates the value of genomic and epigenomic methylation sequencing capabilities of Predicine liquid biopsy platform for biomarker discovery, treatment selection, therapy monitoring and minimal residual disease monitoring

See more here:
Predicine to Introduce PredicineALERT™ MRD Assay and Present Twelve Posters at AACR 2023 Conference

Read More...

Biomerica Reports Q3 Fiscal 2023 Results

April 15th, 2023 12:16 am

IRVINE, Calif., April 14, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced its fiscal third quarter and nine month results ended February 28, 2023.

Read more:
Biomerica Reports Q3 Fiscal 2023 Results

Read More...

Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders

April 15th, 2023 12:16 am

PALO ALTO, Calif., April 14, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a subsidiary of Sorrento Therapeutics, Inc. (OTC Market: SRNEQ) (“Sorrento”), announced today that the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”) that was scheduled to be held at 9:00 a.m. (Pacific Time) on Monday, April 17, 2023, has been postponed to Thursday, May 4, 2023 at 9:00 a.m. (Pacific Time).

Link:
Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders

Read More...

NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV

April 15th, 2023 12:16 am

SANTA ANA, Calif. and THE WOODLANDS, Texas, April 14, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK Natural Killer (“NK”) cell therapeutics, and Graf Acquisition Corp. IV (NYSE: GFOR, GFOR.U, GFOR WS) (“Graf”), a New York Stock Exchange-listed special purpose acquisition company founded by serial SPAC founder James Graf, along with Sabrina McKee and Tony Kuznik, announced today that they have entered into a definitive agreement (the “Merger Agreement”) for a business combination(the “Business Combination”). Upon the closing of the Business Combination, Graf will be renamed “NKGen Biotech, Inc.” and is expected to be listed on the New York Stock Exchange, NYSE American or Nasdaq under the ticker symbol “NKGN”.

See the original post here:
NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV

Read More...

Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? – InvestorsObserver

April 7th, 2023 12:24 am

Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry?  InvestorsObserver

Originally posted here:
Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver

Read More...

Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? – InvestorsObserver

April 7th, 2023 12:24 am

Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday?  InvestorsObserver

See original here:
Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver

Read More...

Where Does Ambrx Biopharma Inc – ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? – InvestorsObserver

April 7th, 2023 12:24 am

Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week?  InvestorsObserver

Excerpt from:
Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver

Read More...

Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? – InvestorsObserver

April 7th, 2023 12:24 am

Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week?  InvestorsObserver

See the original post here:
Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver

Read More...

International Carrot Day: From healthy eyesight to weight loss – 5 wonderful benefits of carrot – Zee Business

April 7th, 2023 12:23 am

International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot  Zee Business

See original here:
International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot - Zee Business

Read More...

What is ophthalmology? Medical conditions, procedures, and more

April 7th, 2023 12:23 am

Ophthalmology is the study of medical conditions relating to the eye. Ophthalmologists are doctors who specialize in the medical and surgical treatment of this organ.

A general practice doctor may refer someone to an ophthalmologist if they show symptoms of cataracts, eye infections, optic nerve problems, or other eye conditions.

In this article, we look at what ophthalmologists do, including the types of conditions that they treat, the procedures they perform, and when a person might see this specialist.

An ophthalmologist is a medical doctor who specializes in diagnosing and treating eye-related conditions.

To practice in the United States, ophthalmologists must complete:

Some ophthalmologists undergo a year or two of fellowship training specializing in one of the many subspecialties of ophthalmology, such as:

Subspecialist ophthalmologists have usually completed training that allows them to work on eye conditions that are complex, involve a specific part of the eye, or affect certain groups of people. They also train more extensively than regular ophthalmologists to perform extremely intricate surgeries on delicate parts of the eye.

Ophthalmologists are responsible for the diagnosis, prevention, and treatment of almost all eye conditions and visual issues.

However, subspecialist ophthalmologists tend to treat and monitor certain conditions, such as:

Aside from caring for the eyes and vision, an ophthalmologists medical training may also equip them to notice symptoms of conditions that do not directly relate to the eye. In such cases, they can refer people for the appropriate treatment.

Many ophthalmologists also participate in some form of scientific research focusing on the causes of eye and vision conditions, as well as potential cures.

Most ophthalmologists are trained and certified to perform a wide range of medical and surgical procedures. The procedures that an ophthalmologist regularly carries out depend on several factors, such as the type of practice and specialty in which they work.

Some of the most common everyday procedures that an ophthalmologist will perform include diagnosing and monitoring mild eye and vision conditions. They will also spend time prescribing and fitting glasses and contact lenses to correct vision problems.

Subspecialist ophthalmologists tend to perform a smaller range of procedures on a day-to-day basis, focusing instead on the treatment of one condition or a few related conditions.

Procedures that subspecialists commonly perform include:

Most people see an ophthalmologist because they are experiencing chronic or severe vision symptoms or signs of eye conditions, such as:

A person may need emergency care from an ophthalmologist if their symptoms include:

A person may also receive a referral to an ophthalmologist if they have conditions or factors that can increase the risk of eye conditions, such as:

A family doctor, pediatrician, emergency room doctor, or optometrist usually refers a person to an ophthalmologist.

The American Academy of Ophthalmology recommend that people have a full medical eye exam by the age of 40 years so that an ophthalmologist can create a baseline profile of their eye health.

Having an eye health baseline is important because it makes it easier for doctors to spot or track eye or vision changes, which are often subtle and difficult to detect. Even healthy people can suddenly experience severe eye conditions.

Unlike ophthalmologists, optometrists and opticians are not medical doctors. However, members of all three distinct professions can, and frequently do, work in the same office or practice.

Optometrists are healthcare professionals who provide primary vision care. Optometrists hold a Doctor of Optometry (OD) degree, which requires the completion of 34 years of college and then 4 years of optometry school.

While the procedures that they perform vary between states and individual practices or clinics, most optometrists:

Opticians are a type of healthcare technician. They are specially trained to help design, confirm, select, or fit corrective vision devices, including contact lenses and eyeglass lenses and frames. Opticians cannot diagnose or treat conditions and must follow the prescription and guidance of optometrists and ophthalmologists.

The other eye healthcare professionals who frequently work with ophthalmologists and optometrists include:

Ophthalmologists are medical doctors who have undergone specialist training to diagnose and treat conditions involving the eyes and vision. They perform a wide range of medical and vision tests, minor office procedures, and some surgeries.

Some ophthalmologists specialize in a specific branch of ophthalmology that deals with particular procedures, parts of the eye, or groups of people.

A family doctor, pediatrician, or emergency room doctor usually refers a person to an ophthalmologist because of eye or vision problems. They refer people with symptoms and signs of conditions that need treating or monitoring.

Someone might also see an ophthalmologist if they have a higher risk of eye conditions or have health conditions that often lead to vision problems.

According to eye health authorities, most people should have an ophthalmologist perform a complete eye exam before the age of 40 years to establish a baseline profile of their eye health.

Link:
What is ophthalmology? Medical conditions, procedures, and more

Read More...

Optometrist vs. Ophthalmologist: Choosing Your Eye Care Provider

April 7th, 2023 12:23 am

If youve ever had to search for an eye care doctor, youre likely aware that there are several different types of eye specialists. Optometrists, ophthalmologists, and opticians are all professionals who specialize in eye care.

An optometrist is an eye doctor that can examine, diagnose, and treat your eyes. An ophthalmologist is a medical doctor who can perform medical and surgical interventions for eye conditions. An optician is a professional who can help fit eyeglasses, contact lenses, and other vision-correcting devices.

In this article, we will explore the education requirements, salary, scope of practice, and services that optometrists, ophthalmologists, and opticians provide. We will also discuss how to choose the best eye-care professional for your needs.

An optometrist is the primary health care provider for routine eye care.

An optometry program is a postgraduate program that takes roughly 4 years to complete, depending on the school and curriculum. The program curriculum includes:

Optometry program coursework also includes full-time clinical training as a resident during the final 1 to 2 years of the program.

In 2018, the median salary for optometrists was $111,790, according to the Bureau of Labor Statistics.

You can visit an optometrist for your yearly eye exam, to refill an eyeglass or contact prescription, or even to receive medication and treatment for certain eye conditions. Unlike an ophthalmologist, an optometrist is not a surgical specialist and cannot treat more serious eye conditions.

Optometrists provide the following services::

Optometrists can prescribe controlled medications for eye conditions. Depending on the state legislation, some optometrists can also perform minor surgeries. These surgical procedures may include foreign body removal, laser eye surgery, and certain additional surgical interventions.

An ophthalmologist is a medical doctor who specializes in surgical eye procedures.

All ophthalmologists must complete a full medical program before they can begin a residency program in ophthalmology. An ophthalmology residency program takes an additional 4 to 7 years to complete, depending on the school and curriculum. The residency program expands on:

Ophthalmology residency training also includes the hands-on care of patients, which involves performing surgical procedures under supervision. The residency program generally follows a one year internship.

In 2018, the average salary for ophthalmologists was $290,777 according to Salary.com.

You can visit an ophthalmologist for the same care as an optometrist, such as a routine eye exam or prescription refill. However, an ophthalmologist can also perform eye surgery for various diseases and conditions, including cataracts, glaucoma, and strabismus surgery, plus more.

Ophthalmologists provide the following services:

Ophthalmologists receive 12 or more years of training in order to be able to perform in-depth surgical procedures for diseases of the eyes. Given that this is their specialty, almost all ophthalmologists will focus on this as their primary scope of care.

Depending on the scope of practice within the state, both optometrists and ophthalmologists can perform eye surgery. However, optometrists are limited in the surgeries they can perform while ophthalmologists can perform any and all surgical procedures they are trained for.

An optician is a customer service representative who works in a vision care store or optometrists office.

Optician training is much more informal than optometry or ophthalmology training. An optician does not necessarily need to hold a formal degree. An optician can become certified by completing a 1- to 2-year program, such as an associates program in ophthalmic dispensing.

An optician may also become certified through an in-house apprenticeship under an ophthalmologist or optometrist.

In 2018, the median salary for opticians was $37,010 according to the Bureau of Labor Statistics.

Opticians perform customer service duties at your optometrists office or local vision care center. You can visit an optician for routine care, adjustment, and refilling of prescription eyeglasses and contact lenses.

Opticians can also answer general eye care questions, but they cannot examine, diagnose or treat diseases of the eye.

Opticians provide the following services:

Unlike optometrists and ophthalmologists, opticians are not allowed to perform any eye exams or diagnose or treat any eye conditions.

How do you know which provider you should choose for your eye care? Choosing an optometrist, ophthalmologist, or optician will depend on the service you need.

Optometrists, ophthalmologists, and opticians are all eye care professionals who differ in their education, specialty, and scope of practice.

Optometrists are basic eye care specialists who can examine, diagnose, and medically treat eye conditions. Ophthalmologists are a type of medical doctor who specialize in surgical procedures of the eye. Opticians are customer service specialists who work in vision care centers and optometry offices.

Choosing the right eye care professional for you will depend on what services you need. For a comprehensive list of optometrists near you, check out the American Optometric Associations Find a Doctor tool.

Read the original:
Optometrist vs. Ophthalmologist: Choosing Your Eye Care Provider

Read More...

Ophthalmology Services & Information | UCLA Health

April 7th, 2023 12:23 am

Aesthetic Center

Experts treat patients who want to enhance their appearance through surgery. For example, treatment might involve eyelid reshaping, fat transfer or liposuction to alter a persons facial features. Patients who want aesthetic surgery receive care from specialists trained in both ophthalmic and plastic surgery.

UCLA Health ophthalmology conductsresearch in public health ophthalmology and provide high-impact, community-based services. For example, our Mobile Eye Clinic improves access to care in underserved communities.

Specialists use a team approach to research blinding diseases. Private donations, including an endowment established by the Ahmanson Foundation, fund this research center, established in 1997.

We provide core support for studies that include patient care. Every clinical trial and study involves vital, behind-the-scenes details that enable us to continue this research. At present, we are conducting almost 80 clinical research studies to help us better understand eye disorders and treatments.

Our ophthalmologists specialize in treating patients with diabetes-related eye conditions. Established more than a decade ago, the center has contributed significantly both to the understanding and the care of eye diseases in people with diabetes.

Specialists provide ultramodern vision correction treatments. We were one of a limited number of study sites in the United States that participated in the Food and Drug Administration (FDA) clinical trial of excimer laser technology. We also were the first site in Los Angeles to use FDA-approved laser treatment to correct myopia (nearsightedness) and astigmatism (imperfect eye curvature).

Our team offers high-quality care and rehabilitation and promotes collaborative research for macular degeneration (an eye disease that causes vision loss). Patients in this program, established in 1994, often have access to new treatments through clinical trials.

For more than 40 years, weve provided eye exams and screenings in neighborhoods where poverty and vision disabilities intersect. This 39-foot-long bus is outfitted with equipment for eye exams and supported by charitable donations. Each year, we provide eye care to more than 20,000 underserved adults and children in Southern California.

We established this center in 1985 to coordinate research, education and patient care of inflammatory eye disorders. Inflammatory diseases include those that cause eye swelling and destroy tissue. We have a long history of participating in clinical and drug therapy trials that advance our understanding of these diseases.

Specialists have renowned expertise in teaching, research and clinical management of tumors. Our program has achieved international recognition for the diagnosis and treatment of ocular melanoma (cancer of the eye).

We serve as a hub for national, long-term studies that investigate eye cancer. We also played an important role in the Collaborative Ocular Melanoma Study, a significant research initiative sponsored by the National Eye Institute.

Experts treat conditions that affect the optic nerve. Your optic nerves carry images from your eyes to your brain so you can see. If you have an optic nerve condition, your treatment might involve the expertise of ophthalmologists, orbital surgeons, neurologists, neuroradiologists or neurosurgeons.

We study and treat orbital (bony eye socket) diseases brought on by trauma, cancer, inflammation or infection. Our multidisciplinary collaboration offers patients a level of knowledge and expertise not found elsewhere in Southern California. We also have an active program in thyroid eye diseases, through which we study eye conditions that also affect your endocrine system.

We address the full spectrum of hereditary eye disorders (disorders you inherit from your parents). We offer diagnosis and treatment, as well as genetic counseling or DNA testing when appropriate.

Specialists in the Vision Genetics Center, established in 1978, collaborate with genetic research groups around the world. Our efforts ensure that patients have access to the most advanced treatments and clinical trials.

Our team provides rehabilitation services to help people with low vision maximize their function and improve their quality of life. We tailor the treatment plan to a patients individual goals and can help anyone who has difficulty with visual tasks, such as reading.

We also conduct research studies and pioneer novel ways to help people with vision loss. For example, we developed a system that uses rehabilitation delivered virtually to increase access to care. The approach involves video conferencing with a doctor. Now, we are part of a national, multicenter trial to evaluate how this new approach can improve reading ability.

Our specialists are experts in diagnosis, treatment and management of all conditions that affect the eyes, including pediatric vision concerns. Common conditions we treat include:

Astigmatism: An imperfect curving of your eye that causes blurry vision.

Blepharitis: Eyelid inflammation that can lead to dry eyes, redness or swelling.

Cataracts: When proteins build up in your eye and cause cloudy or fuzzy vision.

Conjunctivitis (pinkeye): Inflammation or infection in your eye that causes itching, redness and crusting around the eye.

Glaucoma: Conditions that damage your optic nerve (nerve that carries images to your brain), often caused by a buildup of pressure in your eye.

Macular degeneration: Deterioration of your retina (the back part of your eye that interprets and sends images to your brain).

Myopia (nearsightedness): A common vision condition in which you can focus on close objects but not on objects that are far away.

Our goal is to find the best, most effective treatment options for eye conditions. We provide a range of nonsurgical and surgical treatments.

Our specialists care for both routine and complex eye conditions. Nonsurgical treatments we offer include:

Anti-glare glasses: Devices designed to improve vision while reducing eye strain.

Artificial tears: Eyedrops that improve lubrication and moisture on your eyes surface.

Contact lenses: Thin devices placed directly over your eyes surface to improve vision.

Eye drops: Drops that contain saline and medication such as steroids or antihistamines.

Eye patches: A device made of cloth, plastic or an adhesive bandage that covers the eye.

Warm compresses for your eyes: Applying a clean, warm cloth over your eyes to relieve swelling, pain or inflammation.

We offer research-based, advanced surgical treatments for a range of eye conditions. Common surgeries include:

Blepharoplasty: Plastic surgery to change the appearance of your eyelids, often by correcting droopiness.

Corneal transplant: Repairing your cornea (transparent tissue that covers your eye) with donor tissue.

Orbital decompression: Removing fat or bone from behind the eye so that your eye sits back further in its socket.

Photodynamic therapy: Combining light energy with specific drugs to destroy precancerous or cancerous cells.

Pneumatic retinopexy: Injecting your eye with a small air bubble to push the retina in place while your surgeon repairs retinal tears.

Strabismus surgery: Surgically loosening or tightening eye muscles to correct irregular eye alignment (crossed eyes).

Vitrectomy: Removing fluid from the eye to treat problems with the retina or vitreous humor (the gel-like tissue that fills your eyeball).

The specialists on our ophthalmology team have led the way in the research and clinical care of eye conditions. We use the latest techniques and have pioneered advanced treatment options.

Call 310-825-5000 to request an appointment with an eye specialist at UCLA Health.

Original post:
Ophthalmology Services & Information | UCLA Health

Read More...

About Regenerative Medicine – Center for Regenerative … – Mayo Clinic

April 7th, 2023 12:22 am

Andre Terzic, M.D., Ph.D.

Center for Regenerative Biotherapeutics, Mayo Clinic

Andre Terzic, M.D., Ph.D.: Regenerative medicine is an exciting component of modern health care. It harnesses breakthroughs in technologies to address major unmet needs of the population, both nationally but also globally. With the successes of traditional medicine, we'll live longer. And aging has been viewed as a major triumph of humanity. At the same time, unfortunately, with aging, we are facing with a growing pandemic of so-called chronic diseases diseases that live with us throughout our lifespan, heart disease, cancer, diabetes and so on.

So regenerative medicine comes with this new ability to understand how our body can heal and to harness its innate ability, that self-ability to heal, to actually provide new solutions to these patients in need. So the Center for Regenerative Biotherapeutics at Mayo Clinic has been built to address the unmet needs of patients. It builds on our new knowledge, bringing new ways to promote the self-repair ability of our body.

There have been magic moments during these few decades that we have built the regenerative medicine field. One such moment was when we saw, for the first time, how out of a stem cell, we can create new beating heart tissue. It was a revolution for us.

We would like to bring now this knowledge that may have started in one field to build it across fields as the new science allows, essentially, for learning between fields. We need true, radical innovation to move the current knowledge into new solutions. That is where regenerative medicine has a unique role. It changes the way we treat patients.

Visit link:
About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic

Read More...

Regenerative Medicine | National Institutes of Health (NIH)

April 7th, 2023 12:22 am

Instead of trying to compensate for failing organs, what if we could readily replace diseased or injured body parts with brand-new versions made in the lab? Researchers working in the field of regenerative medicine have already made amazing progress, creating artificial organs and miniature labs-on-a-chip. The return on investment for this area of research is expected to be dramatic: better understanding of how diseases develop and spread, accurate screens for testing new drugs, and cell-based therapies for diabetes, arthritis, Parkinsons disease, and many other conditions that affect millions of Americans. NIH researchers have already created miniature hearts that beat rhythmically in a culture dish and contain all the different cell types that make up a human heart. Scientists have also developed a lung-on-a-chip. When intermittent suction is applied, the cells in this thumb-sized device flex and stretch rhythmically just as they do in our lungs when we breathe. For individuals with kidney failure, the potential of using their own skin cells to build a new kidney might now be within reach given years of hard work and the necessary research investment.

Each year, NIH research funding can be expected to generate more than 100 new inventions..

Previous: The Future of Biomedicine Next: The CRISPR Revolution

This page last reviewed on February 28, 2023

Continued here:
Regenerative Medicine | National Institutes of Health (NIH)

Read More...

Page 103«..1020..102103104105..110120..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick